GYEMSZI - MOB

Heimesaat, Markus M. - Kapcsolódó tételek

1.			Absinthe against multi-drug resistant bacterial pathogens? : a recent update on the antibacterial effects of Artemisia compounds
2.			Antibacterial effects of biologically active ingredients in hop provide promising options to fight infections by pathogens including multi-drug resistant bacteria
3.			Antibacterial effects of vanilla ingredients provide novel treatment options for infections with multidrug-resistant bacteria - A recent literature review
4.			Antibacterial properties of capsaicin and its derivatives and their potential to fight antibiotic resistance - A literature survey
5.			Anti-inflammatory effects of the octapeptide NAP in human microbiota-associated mice suffering from subacute ileitis
6.			Anti-Inflammatory Properties of NAP in Acute Toxoplasma gondii-Induced Ileitis in Mice
7.			Antimicrobial and Immune-Modulatory Effects of Vitamin D Provide Promising Antibiotics-Independent Approaches to Tackle Bacterial Infections - Lessons Learnt from a Literature Survey
8.			Binary surrogate endpoints in clinical trials from the perspective of case definitions
9.			Campylobacter jejuni infection induces acute enterocolitis in IL-10-/- mice pretreated with ampicillin plus sulbactam
10.			Can microbiota transplantation abrogate murine colonization resistance against Campylobacter jejuni?
11.			Carvacrol prophylaxis improves clinical outcome and dampens apoptotic and pro-inflammatory immune responses upon Campylobacter jejuni infection of human microbiota-associated IL-10-/- mice
12.			Changes of the intestinal microbiome-host homeostasis in HIV-infected individuals - a focus on the bacterial gut microbiome
13.			Chronic otitis media following infection by non-O1/non-O139 Vibrio cholerae: A case report and review of the literature
14.			Colonic Expression of Genes Encoding Inflammatory Mediators and Gelatinases During Campylobacter Jejuni Infection of Conventional Infant Mice
15.			Colonization resistance against genetically modified Escherichia coli K12 (W3110) strains is abrogated following broad-spectrum antibiotic treatment and acute ileitis
16.			Commensal microbiota drive proliferation of conventional and Foxp3+ Regulatory CD4+ T cells in mesenteric lymph nodes and Peyer's patches
17.			Comprehensive survey of intestinal microbiota changes in offspring of human microbiota associated mice
18.			The conundrum of colonization resistance against Campylobacter reloaded: The gut microbota composition in conventional mice does not prevent from Campylobacter coli infection
19.			Dissecting the interplay between intestinal microbiota and host immunity in health and disease: Lessons learned from germfree and gnotobiotic animal models
20.			Evaluation of the Xiamen AmonMed Biotechnology rapid diagnostic test COVID-19 IgM/IgG test kit (Colloidal gold)
21.			Fecal Microbiota Transplantation Decreases Intestinal Loads of Multi-Drug Resistant Pseudomonas aeruginosa in Murine Carriers
22.			Finding novel antibiotic substances from medicinal plants - Antimicrobial properties of Nigella sativa directed against multidrug resistant bacteria
23.			Function of serine protease HtrA in the lifecycle of the foodborne pathogen Campylobacter jejuni
24.			Human microbiota associated IL-10-/- mice: A valuable enterocolitis model to dissect the interactions of Campylobacter jejuni with host immunity and gut microbiota
25.			Immunomodulatory and Antimicrobial Effects of Vitamin C
26.			The impact of ketogenic diet on the onset and progression of multiple sclerosis
27.			Impact of metal ion homeostasis of genetically modified Escherichia coli Nissle 1917 and K12 (W3110) strains on colonization properties in the murine intestinal tract
28.			Intestinal expression of genes encoding inflammatory mediators and gelatinases during Arcobacter butzleri infection of gnotobiotic IL-10 deficient mice
29.			Intestinal microbiota changes in mice lacking pituitary adenylate cyclase activating polypeptide (PACAP) - bifidobacteria make the difference
30.			A literature survey on antimicrobial and immune-modulatory effects of butyrate revealing non-antibiotic approaches to tackle bacterial infections
31.			Matrix Metalloproteinase-2 Mediates Intestinal Immunopathogenesis in Campylobacter jejuni-infected infant mice
32.			Microbiota composition and immune responses during Campylobacter jejuni infection in conventionally colonized IL-10-/- mice lacking nucleotide oligomerization domain 2
33.			Microbiota composition and inflammatory immune responses upon peroral application of the commercial competitive exclusion product Aviguard(R) to microbiota-depleted wildtype mice
34.			Modulation of the intestinal microbiota impacts the efficacy of immunotherapy in cancer patients - A recent literature survey
35.			Multidrug-resistant Pseudomonas aeruginosa induce systemic pro-inflammatory immune responses in colonized mice
36.			Not only for Christmas: Prophylactic oral application of trans-cinnamaldehyde alleviates acute murine campylobacteriosis
37.			Oral application of carvacrol, butyrate, ellagic acid, and 2'-fucosyl-lactose to mice suffering from acute campylobacteriosis - Results from a preclinical placebo-controlled intervention study
38.			Peroral low-dose Toxoplasma gondii infection of human microbiota-associated mice - a subacute ileitis model to unravel pathogen-host interactions
39.			Phage therapy in lung infections caused by multidrug-resistant Pseudomonas aeruginosa - A literature review
40.			Phage therapy in prosthetic joint infections caused by Staphylococcus aureus - A literature review
41.			Polyphenolic compounds in the combat of foodborne infections - An update on recent evidence
42.			Prophylactic oral application of resveratrol to alleviate acute campylobacteriosis in human gut microbiota associated IL-10-/- mice
43.			A review of the antimicrobial and immune-modulatory properties of the gut microbiota-derived short chain fatty acid propionate - What is new?
44.			Review of therapeutic options for infections with carbapenem-resistant Klebsiella pneumoniae
45.			The role of gelatinases in Campylobacter jejuni infection of gnotobiotic mice
46.			The Role of IL-23, IL-22, and IL-18 in Campylobacter Jejuni Infection of Conventional Infant Mice
47.			Saponins increase susceptibility of vancomycin-resistant enterococci to antibiotic compounds
48.			Small intestinal pro-inflammatory immune responses following Campylobacter jejuni infection of secondary abiotic IL-10-/- mice lacking nucleotide-oligomerization-domain-2
49.			Survey of extra-intestinal immune responses in asymptomatic long-term Campylobacter jejuni-infected mice
50.			Synergistic Antimicrobial Effects of Cefabronchin

Mind kijelölve: